Navigation Links
Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
Date:9/11/2007

Federal, State and Local Officials Scheduled to Attend Ceremony

CHESTER, N.J., Sept. 11 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) announced that it will commemorate the 10th anniversary of its incorporation with a celebration for employees on Wednesday, Sept. 12, at Municipal Field (Gazebo Park) in Chester, New Jersey. Federal, state and local officials are scheduled to attend and participate in a ceremony recognizing Adams for its decade of success as a specialty pharmaceutical company focused on the treatment of respiratory disorders.

Adams, best known for its Mucinex(R) and Delsym(R) cough and cold products and the nationwide Mr. Mucus(TM) consumer advertising campaign, commenced operations in Fort Worth, Texas in September 1997. In April 2004, the Company relocated its corporate headquarters from Fort Worth to Chester, New Jersey. Adams currently employees nearly 500 people and its Chester facility houses more than 80 of its employees. The Company has expanded its headquarter operations twice since relocating to Chester in 2004 and doubled its portfolio of marketed respiratory products this year.

"On the occasion of this important milestone, I applaud our employees, whose talents and tireless efforts have fueled Adams' phenomenal growth in the past several years," said Michael J. Valentino, president & CEO. "I'm proud of our accomplishments and I look forward to a second decade of success with multiple new product introductions and our planned expansion into the prescription respiratory market."

"I congratulate Adams Respiratory Therapeutics on its 10-year anniversary, and the tremendous growth and success that this company has achieved in such a short period of time," said Stanley Kosierowski, COO and SVP business support, New Jersey Economic Development Authority, who is scheduled to attend the celebration on September 12. "It is New Jersey's good fortune to have companies like Adams come to our state, where they create jobs, become good neighbors and corporate citizens, and continue New Jersey's fine tradition of improving public health by providing important medicines for the entire nation."

In August 2007, Adams was named to Deloitte & Touche's prestigious Technology Fast 50 Program for New Jersey, a ranking of the 50 fastest growing technology, media, telecommunications, and life sciences companies in the area. Adams was ranked No. 7 overall, based on achieving a revenue growth rate of 1,638 percent from 2002 to 2006.

About Adams Respiratory Therapeutics, Inc.

Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.

For additional information about Adams, please visit the web site at http://www.adamsrt.com.


'/>"/>
SOURCE Adams Respiratory Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Passive smoking affects respiratory system
2. Occupational exposurer aises respiratory symptoms
3. Severe Acute respiratory Syndrome (SARS)
4. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
5. Good News for New Borns With Hypoxic Respiratory Failure
6. Understanding The Link Between Hormone Replacement and Respiratory Disease
7. Hand sanitizers may reduce respiratory and gastrointestinal infections at home
8. Antibiotics for acute uncomplicated lower respiratory tract infection
9. Handwashing prevents diarrhea and acute lower respiratory infections
10. New Virus Held Responsible For Respiratory Infection In Children
11. Second Hand Exposure To Smoke In Childhood Can Cause Respiratory Problems Later
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: